Cordlife Group (SGX:P8A) EV-to-EBIT : -5.66 (As of Jun. 07, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cordlife Group's Enterprise Value is S$-25.62 Mil. Cordlife Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$4.53 Mil. Therefore, Cordlife Group's EV-to-EBIT for today is -5.66.

The historical rank and industry rank for Cordlife Group's EV-to-EBIT or its related term are showing as below:

SGX:P8A' s EV-to-EBIT Range Over the Past 10 Years
Min: -6.72 Med: 10.26 Max: 2351.64
Current: -5.66

During the past 12 years, the highest EV-to-EBIT of Cordlife Group was 2351.64. The lowest was -6.72. And the median was 10.26.

SGX:P8A's EV-to-EBIT is ranked better than
98.97% of 97 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.36 vs SGX:P8A: -5.66

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cordlife Group's Enterprise Value for the quarter that ended in Dec. 2023 was S$19.55 Mil. Cordlife Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$4.53 Mil. Cordlife Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 23.15%.

Cordlife Group EV-to-EBIT Historical Data

The historical data trend for Cordlife Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group EV-to-EBIT Chart

Cordlife Group Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

10.39

5.89

5.65

3.40

4.32

Cordlife Group Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															5.65	-	3.40	-	4.32

Competitive Comparison of Cordlife Group's EV-to-EBIT

For the Diagnostics & Research subindustry, Cordlife Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cordlife Group's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cordlife Group's EV-to-EBIT falls into.

Cordlife Group EV-to-EBIT Calculation

Cordlife Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	-25.621	/	4.526
	=	-5.66

Cordlife Group's current Enterprise Value is S$-25.62 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cordlife Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$4.53 Mil.

Cordlife Group (SGX:P8A) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cordlife Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	4.526	/	19.55002
	=	23.15 %

Cordlife Group's Enterprise Value for the quarter that ended in Dec. 2023 was S$19.55 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cordlife Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$4.53 Mil.

Cordlife Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cordlife Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordlife Group (SGX:P8A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

CLIFF:USA

Address

1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160

Website

https://www.cordlife.com

Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group (SGX:P8A) Headlines

No Headlines